Influenza-associated hospitalization rates vary across seasons, and only returned to recent pre-COVID-19 pandemic levels in the 2022-2023 influenza season.
Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, ...
Although the incidence of spontaneous bacterial empyema in patients with cirrhosis is low, SPEM in this population is associated with a 90-day mortality rate of 41%. Albumin may reduce mortality in ...
Gastrointestinal tract symptoms were prevalent among patients with systemic sclerosis and significantly impacted their quality of life. Gastrointestinal tract (GIT) symptoms significantly impact ...
Semaglutide results in greater reductions in body weight and pain related to knee osteoarthritis than placebo. HealthDay News — For individuals with obesity and knee osteoarthritis, once-weekly ...
The risk for mild dementia reduced by approximately 13% in "weekend warriors." HealthDay News — The “weekend warrior” physical activity pattern is associated with a reduced risk for mild dementia over ...
The World Health Organization reports that tuberculosis (TB) cases hit a record high in 2023, with more than 8 million diagnoses and 1.25 million deaths.
The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.